SCHEMBL2655286

SCHEMBL2655286

CC(CCc1ccc(C(=O)NCCC(=O)O)cc1)COc1ccc(-c2ccc(C(F)(F)F)cn2)cc1

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GCG P01275 3/20 0.53
GCGR P47871 19/20 0.47
GIPR P48546 5/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655266 0.95 GCG (0.55) GCGGCGRGIPR
SCHEMBL2654147 0.90 FFAR1 (0.48) GCGGCGRGIPR
SCHEMBL3778469 0.89 GCG (0.53) GCGGCGRGIPR
SCHEMBL2657520 0.89 GCG (0.56) GCGGCGRGIPR
SCHEMBL2654634 0.85 GCGR (0.48) GCGGCGR
SCHEMBL2650317 0.85 GCG (0.49) GCGGCGRGIPR
SCHEMBL2269792 0.85 GCGR (0.52) GCGGCGRGIPR
SCHEMBL2653386 0.85 GCG (0.48) GCGGCGRGIPR
SCHEMBL2654285 0.84 GCG (0.48) GCGGCGRGIPR
SCHEMBL2655270 0.84 GCGR (0.53) GCGRGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP claimed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO claimed
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed